| Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells TCT Lan, MF Allan, LE Malsick, JZ Woo, C Zhu, F Zhang, S Khandwala, ... Nature communications 13 (1), 1128, 2022 | 114 | 2022 |
| A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer C Zhu, L Li, Z Zhang, M Bi, H Wang, W Su, K Hernandez, P Liu, J Chen, ... Molecular cell 75 (4), 791-806. e8, 2019 | 97 | 2019 |
| A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion T Ikenoue, Y Terakado, H Nakagawa, Y Hikiba, T Fujii, D Matsubara, ... Scientific reports 6 (1), 23899, 2016 | 84 | 2016 |
| An intranasal ASO therapeutic targeting SARS-CoV-2 C Zhu, JY Lee, JZ Woo, L Xu, X Nguyenla, LH Yamashiro, F Ji, SB Biering, ... Nature communications 13 (1), 4503, 2022 | 54 | 2022 |
| SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling SB Biering, FT Gomes de Sousa, LV Tjang, F Pahmeier, C Zhu, R Ruan, ... Nature Communications 13 (1), 7630, 2022 | 45 | 2022 |
| Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells T Ohsugi, K Yamaguchi, C Zhu, T Ikenoue, K Takane, M Shinozaki, ... Oncogene 38 (32), 6051-6064, 2019 | 30 | 2019 |
| Decreased expression of interferon-induced protein 2 (IFIT2) by Wnt/β-catenin signaling confers anti-apoptotic properties to colorectal cancer cells T Ohsugi, K Yamaguchi, C Zhu, T Ikenoue, Y Furukawa Oncotarget 8 (59), 100176, 2017 | 24 | 2017 |
| Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells X Nguyenla, E Wehri, E Van Dis, SB Biering, LH Yamashiro, C Zhu, ... Scientific reports 12 (1), 18506, 2022 | 23 | 2022 |
| Bidirectional reporter assay using HAL promoter and TOPFLASH improves specificity in high‐throughput screening of Wnt inhibitors K Yamaguchi, C Zhu, T Ohsugi, Y Yamaguchi, T Ikenoue, Y Furukawa Biotechnology and Bioengineering 114 (12), 2868-2882, 2017 | 14 | 2017 |
| Identification of FERM domain‐containing protein 5 as a novel target of β‐catenin/TCF 7L2 complex C Zhu, K Yamaguchi, T Ohsugi, Y Terakado, R Noguchi, T Ikenoue, ... Cancer science 108 (4), 612-619, 2017 | 12 | 2017 |
| Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis X Liu, K Yamaguchi, K Takane, C Zhu, M Hirata, Y Hikiba, S Maeda, ... PLoS One 16 (9), e0257090, 2021 | 11 | 2021 |
| Establishment and analysis of a novel mouse line carrying a conditional knockin allele of a cancer-specific FBXW7 mutation T Ikenoue, Y Terakado, C Zhu, X Liu, T Ohsugi, D Matsubara, T Fujii, ... Scientific reports 8 (1), 2021, 2018 | 10 | 2018 |
| Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells. Nat Commun 13: 1128 TCT Lan, MF Allan, LE Malsick, JZ Woo, C Zhu, F Zhang, S Khandwala, ... | 9 | 2022 |
| Bromodomain protein BRD8 regulates cell cycle progression in colorectal cancer cells through a TIP60-independent regulation of the pre-RC complex K Yamaguchi, S Nakagawa, A Saku, Y Isobe, R Yamaguchi, P Sheridan, ... Iscience 26 (4), 2023 | 5 | 2023 |
| Correction: Corrigendum: A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion T Ikenoue, Y Terakado, H Nakagawa, Y Hikiba, T Fujii, D Matsubara, ... Scientific Reports 7 (1), 39567, 2017 | 3 | 2017 |
| Establishment and analysis of a novel mouse line carrying a conditional knockin allele of cancer-specific FBXW7 mutation X Liu, T Ikenoue, Y Terakado, C Zhu, T Ohsugi, D Matsubara, T Fujii, ... CANCER SCIENCE 109, 387-387, 2018 | | 2018 |
| Wnt signaling induces anti-apoptotic effect in colorectal cancer cells through the suppression of IFITs T Ohsugi, K Yamaguchi, C Zhu, T Ikenoue, Y Furukawa Cancer Research 77 (13_Supplement), 373-373, 2017 | | 2017 |
